Exciting press coverage following our Polθ (Pol-theta) press release – Nature Communications

July 1, 2021
Media coverage

Please click on links to see full press coverage:

Drug Discovery news           A small molecule inhibitor blocks breast cancers back up plan

FierceBiotech  

Targeting treatment-resistant BRCA-mutated tumors via the newly discovered POLQ pathway

BioWorld  

Artios heads to the clinic with first ever POLQ inhibitor trial

Pharmatimes  

Researchers identify new drug class with potential in BRCA-mutated tumours

FirstWordPharma  

New drug class could treat range of cancers with faulty BRCA genes

Bloomberg  

Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature

BioSpace  

Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature Communications

The Independent  

Scientists identify ‘hugely exciting’ new drugs that could lead to cancer treatments

The Daily Mail  

Hope for women with the ‘Angelina Jolie’ gene as scientists find drugs that can kill cancer cells but leave healthy ones unharmed

Benzinga  

Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature Communications

News Medical Life Sciences  

Novel drug class shows potential to treat cancer patients with faulty BRCA genes

Newsbreezer  

New class of drugs shows potential for treating cancer patients with defective BRCA genes

Telegraph & Argus  

Hope as new drugs to help treat breast and prostate cancer identified

Industry Update  

Targeting treatment-resistant BRCA mutant tumors via the newly discovered POLQ pathway

Messenger  

Hope as new drugs to help treat breast and prostate cancer identified

IrishNews  

Hope as new drugs to help treat breast and prostate cancer identified

EurekAlert  

New drug class could treat range of cancers with faulty BRCA genes

Gazettelive  

New cancer drug breakthrough could treat diseases triggered by ‘Angelina Jolie gene’

DailyPost  

New cancer drug breakthrough could treat diseases triggered by ‘Angelina Jolie gene’

Bristolpost  

New cancer drug breakthrough could treat diseases triggered by ‘Angelina Jolie gene’

Newsazi  

Artios Pharma Publishes Preclinical Data On The First Selective Small Molecule Polθ Polymerase Inhibitor In Nature Communications

Market Newswire  

Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature Communications

Contact us

Reach out to us.